Education
About Us
Working with TipRanks
Follow Us
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990)
:6990
Total Valuation
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H has a market cap or net worth of HK$94.81B. The enterprise value is HK$69.78B.
Market CapHK$94.81B
Enterprise ValueHK$69.78B
Share Statistics
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H has 162,769,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding162,769,970
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H is ―. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change126.76%
50-Day Moving Average439.42
200-Day Moving Average386.86
Relative Strength Index (RSI)46.17
Average Volume (3m)641.47K
Important Dates
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H upcoming earnings date is Mar 30, 2026, TBA (Confirmed).
Last Earnings DateAug 18, 2025
Next Earnings DateMar 30, 2026
Ex-Dividend Date―
Financial Position
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H is HK$551.22, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$551.22
Price Target Upside36.10% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast―
EPS Growth Forecast―